Highest-materiality recent filing
U.S. Global Investors restates Q3 FY2026 EPS; error overstated EPS by $0.02
Non-reliance on previously issued Q3 FY2026 financials due to weighted-average share calculation error.
U.S. Global Investors Q3 net income $2.7M vs year-ago loss; revenue up 31%
Net income $2.7M ($0.23 EPS) vs net loss $382K ($0.03 loss) in Q3 2025; revenue $2.8M (+31% YoY).
U.S. Global Investors returns to profitability with $1.5M net income, up 378% YoY
Net income of $1.5M ($0.12 EPS) vs $0.3M a year ago; operating revenue $2.3M, up 4% YoY.
U.S. Global Investors reports FY2025 net loss of $334K; revenue down 23% to $8.5M
Net loss of $334K ($0.03 per share) vs net income of $1.3M ($0.09) in FY2024.
U.S. Global Investors Q2 net loss $86K, AUM drops to $1.5B, launches WAR ETF
Net loss of $86K ($0.01/share) vs net income $1.2M a year ago; revenue $2.2M, down 21% YoY.
U.S. Global Investors swings to Q1 net income of $315K; revenue down 31%, AUM at $1.5B
Net income of $315K ($0.02 EPS) vs net loss of $176K (-$0.01) YoY; revenue fell 31% to $2.16M.
U.S. Global Investors FY2024 revenue $10.98M, net income down 58% to $1.33M
Operating revenue $10.98M (down 27% YoY); net income $1.33M ($0.09 EPS) vs $3.15M ($0.22 EPS).
U.S. Global Investors Q3 revenue $2.6M, net loss $35k; AUM down to $1.7B
Operating loss of $488k vs operating income $730k a year ago; net loss $0.00 EPS.
U.S. Global Investors Q2 net income $1.2M ($0.09), up 45% YoY; AUM down to $2.1B
Net income of $1.2M ($0.09 per share) vs net loss $176K in prior quarter; up 45% from $847K ($0.06) year ago.
U.S. Global Investors Q1 FY2024 net loss $176K on revenue decline of 29% YoY
Operating income $215K vs $1.585M YoY; net loss $0.01 per share vs breakeven.
U.S. Global Investors reports FY2023 net income $0.22/share, operating margin 23%, revenue $15.1M
Net income $3.1M ($0.22 per share) vs $3.4M ($0.23) prior year; operating income $3.5M.
U.S. Global Investors receives Nasdaq non-compliance notice for late filing of Q1 FY2024 Form 10-Q
Nasdaq notified GROW on Nov 16, 2023 for failure to timely file Form 10-Q (quarter ended Sep 30, 2023) per Listing Rule 5250(c)(1).
U.S. Global Investors Q1 net income $1.6M ($0.11/sh), rev $3.6M; monthly dividend continued
Net income of $1.6M ($0.11 diluted EPS), up 89% sequentially from prior quarter; vs $0.06 loss a year ago.
U.S. Global Investors Q2 fiscal 2023 net income $0.06 EPS on rev $3.7M, down from $0.24 EPS
Operating income $908K vs $2.94M a year ago; revenue fell 43% to $3.7M.
Non-reliance on FY2022 10-K and Q1 FY2023 10-Q due to overstated fair value of warrants and convertible debentures.
Nasdaq notice dated Feb 16, 2023 for non-compliance with Listing Rule 5250(c)(1) due to late Form 10-Q.
U.S. Global Investors Q1 FY2023: operating income $1.6M, revenue $4.4M, net income $0.01/shr
Net income of $118K ($0.01 per share) vs $2.39M ($0.16) YoY; revenue fell 32% to $4.4M.
Total operating revenue $24.7M (+14% YoY); operating margin 45% vs 38% prior year.
U.S. Global Investors rejects acquisition proposal, expands buyback to $5M, maintains dividend
Board rejects Echo Lake and Deerhaven's unsolicited proposal, citing inadequate value for shareholders.
U.S. Global Investors reports Q3 net loss $846k; revenue $6.2M, down 2.8% YoY
Operating income $2.5M ($0.17/share) with 41% margin; net loss $846k ($0.06 loss) due to $4.5M unrealized losses.
U.S. Global Q2 net income $3.6M ($0.24/sh); revenue $6.6M (+39% YoY); AUM $4.1B
Net income $3.6M ($0.24 diluted EPS), up 50% from prior quarter; operating margin 45%.
U.S. Global Investors Q1 2022 revenue doubles to $6.5M, EPS up 23% to $0.16, AUM hits $4B
Operating revenue $6.5M, up >100% YoY; net income $2.4M ($0.16 diluted EPS) up 23% YoY.
U.S. Global Investors reports record net income of $32M for FY2021; revenue up 380% YoY
Net income $32.0M ($2.12/diluted share) vs. net loss of $4.7M ($0.31 loss) prior year.
U.S. Global restates Q3 FY21 results; gets Nasdaq deficiency for late filings
Non-cash adjustments increase assets by ~$5.8M and decrease net income by ~$5.6M for periods ended March 31, 2021.
U.S. Global Investors restates March 2021 financials; net income down $5.6M, EPS cut $0.37
Restatement due to fair value errors on HIVE convertible debentures and warrants; securities value increased $5.8M, net income decreased $5.6M.
On January 23, 2025, the board of directors of the Company appointed Bobby Duncan as a member of the Board, increasing the Board from 4 members to 5 members.
Max materiality 0.85 · Median 0.65 · Most common event earnings